Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

Kristian Taipale; Ilkka Liikanen; Juuso Juhila; Riku Turkki; Siri Tahtinen; Matti Kankainen; Lotta Vassilev; Ari Ristimaki; Anniina Koski; Anna Kanerva; Iulia Diaconu; Vincenzo Cerullo; Markus Vaha-Koskela; Minna Oksanen; Nina Linder; Timo Joensuu; Johan Lundin; Akseli Hemminki

doi:10.1038/mt.2015.143

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

Kristian Taipale
, Ilkka Liikanen
, Juuso Juhila
, Riku Turkki
, Siri Tahtinen
, Matti Kankainen
, Lotta Vassilev
, Ari Ristimaki
, Anniina Koski
, Anna Kanerva
, Iulia Diaconu
, Vincenzo Cerullo
, Markus Vaha-Koskela
, Minna Oksanen
, Nina Linder
, Timo Joensuu
, Johan Lundin
, Akseli Hemminki

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Molecular therapy
Volym	24
Nummer	1
Sidor (från-till)	175-183
Antal sidor	9
ISSN	1525-0016
DOI	https://doi.org/10.1038/mt.2015.143
Status	Publicerad - jan. 2016
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3111 Biomedicinska vetenskaper

Åtkomst av dokument

10.1038/mt.2015.143

Citera det här

Taipale, K., Liikanen, I., Juhila, J., Turkki, R., Tahtinen, S., Kankainen, M., Vassilev, L., Ristimaki, A., Koski, A., Kanerva, A., Diaconu, I., Cerullo, V., Vaha-Koskela, M., Oksanen, M., Linder, N., Joensuu, T., Lundin, J., & Hemminki, A. (2016). Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus. Molecular therapy, 24(1), 175-183. https://doi.org/10.1038/mt.2015.143

@article{b7a2cc8d6ec740dc8bea1141c3707659,

title = "Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus",

keywords = "REFRACTORY SOLID TUMORS, T-CELL EXHAUSTION, B-CELLS, IMMUNOTHERAPY, CHEMOTHERAPY, INTERFERON, BLOCKADE, SURVIVAL, MACROPHAGES, VIROTHERAPY, 3111 Biomedicine",

author = "Kristian Taipale and Ilkka Liikanen and Juuso Juhila and Riku Turkki and Siri Tahtinen and Matti Kankainen and Lotta Vassilev and Ari Ristimaki and Anniina Koski and Anna Kanerva and Iulia Diaconu and Vincenzo Cerullo and Markus Vaha-Koskela and Minna Oksanen and Nina Linder and Timo Joensuu and Johan Lundin and Akseli Hemminki",

year = "2016",

month = jan,

doi = "10.1038/mt.2015.143",

language = "English",

volume = "24",

pages = "175--183",

journal = "Molecular therapy",

issn = "1525-0016",

publisher = "Cell Press",

number = "1",

}

Taipale, K, Liikanen, I, Juhila, J, Turkki, R, Tahtinen, S, Kankainen, M, Vassilev, L, Ristimaki, A , Koski, A , Kanerva, A, Diaconu, I, Cerullo, V , Vaha-Koskela, M , Oksanen, M , Linder, N, Joensuu, T, Lundin, J & Hemminki, A 2016, 'Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus', Molecular therapy, vol. 24, nr. 1, s. 175-183. https://doi.org/10.1038/mt.2015.143

TY - JOUR

T1 - Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

AU - Taipale, Kristian

AU - Liikanen, Ilkka

AU - Juhila, Juuso

AU - Turkki, Riku

AU - Tahtinen, Siri

AU - Kankainen, Matti

AU - Vassilev, Lotta

AU - Ristimaki, Ari

AU - Koski, Anniina

AU - Kanerva, Anna

AU - Diaconu, Iulia

AU - Cerullo, Vincenzo

AU - Vaha-Koskela, Markus

AU - Oksanen, Minna

AU - Linder, Nina

AU - Joensuu, Timo

AU - Lundin, Johan

AU - Hemminki, Akseli

PY - 2016/1

Y1 - 2016/1

KW - REFRACTORY SOLID TUMORS

KW - T-CELL EXHAUSTION

KW - B-CELLS

KW - IMMUNOTHERAPY

KW - CHEMOTHERAPY

KW - INTERFERON

KW - BLOCKADE

KW - SURVIVAL

KW - MACROPHAGES

KW - VIROTHERAPY

KW - 3111 Biomedicine

U2 - 10.1038/mt.2015.143

DO - 10.1038/mt.2015.143

M3 - Article

SN - 1525-0016

VL - 24

SP - 175

EP - 183

JO - Molecular therapy

JF - Molecular therapy

IS - 1

ER -